Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par pays : Romania
Femme et Homme Max 99 ans
Samuel Adler, Prof
MAJ Il y a 4 ans
PillCam SB3 Capsule- Feasibility Study
Study hypothesis: PillCam SB3 is a new capsule designed to provide an improved image quality, and improved SB and duodenum tissue coverage due to Adaptive Frame Rate (AFR) of 2-6 fps, whic...
Pays
Israel
,
Romania
,
Spain
,
Sweden
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
First Presentation of Parkinson Disease Patients to Neurologist
In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time
Pays
Croatia
,
Czech Republic
,
Estonia
,
Hungary
,
Romania
,
Russian Federation
,
Serbia
,
Slovakia
,
Slovenia
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Robert J. Motzer, MD
MAJ Il y a 4 ans
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to com...
Pays
Argentina
,
Bulgaria
,
Canada
,
Chile
,
Czech Republic
,
France
,
Hungary
,
India
,
Italy
,
Poland
,
Romania
,
Russian Federation
,
Serbia
,
Ukraine
,
United Kingdom
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 6 ans
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD)
This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease.
Pays
Canada
,
France
,
Germany
,
Poland
,
Romania
,
Spain
,
Ukraine
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Vicente Torres, MD, PhD
MAJ Il y a 4 ans
Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD
This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.
Pays
Argentina
,
Australia
,
Belgium
,
Canada
,
Denmark
,
France
,
Germany
,
Italy
,
Japan
,
Netherlands
,
Poland
,
Romania
,
Russian Federation
,
United Kingdom
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Thomas Forst, Prof. Dr
MAJ Il y a 4 ans
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
The purpose of this trial is to investigate the efficacy and safety of GRT6005 in patients with painful diabetic neuropathy.
Pays
Bulgaria
,
Germany
,
Romania
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Professor
MAJ Il y a 4 ans
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
The primary objective of this study is to demonstrate the superiority of MCI-196 over placebo and non-inferiority with simvastatin in reducing serum low-density lipoprotein (LDL)-cholester...
Pays
Belarus
,
Bulgaria
,
Croatia
,
Denmark
,
Indonesia
,
Israel
,
Italy
,
Latvia
,
Lithuania
,
Malaysia
,
Romania
,
Singapore
,
Thailand
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.
Pays
Canada
,
Chile
,
Denmark
,
France
,
Germany
,
Italy
,
Poland
,
Romania
,
Russian Federation
,
Ukraine
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
The drug ABR-217620/naptumomab estafenatox is a fusion of two proteins, one that recognizes tumor cells and one that triggers an attack on the tumor cells by activating some white blood ce...
Pays
Bulgaria
,
Romania
,
Russian Federation
,
Ukraine
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Trial of CF101 to Treat Patients With Psoriasis
Eligible patients with Psoriasis will be treated with CF101 or placebo twice daily for 16 weeks. All subjects will receive open-lable CF101 in weeks 17-32.
Pays
Bulgaria
,
Israel
,
Romania
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
6
7
8
9
10
11
12
13
14
15
Suivant